Sarah Bos

14 CHAPTER 1 References 1. Shen J, Sampietro S, Wu J, Tang J, Gupta S, Matzko CN, et al. Coordination of platelet agonist signaling during the hemostatic response in vivo. Blood Adv. 2017;1(27):2767–75. 2. Lisman T, Leebeek FWG, De Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol. 2002;37(2):280–7. 3. Roberts HR, Hoffman M, Monroe DM. A cell-based model of thrombin generation. Semin Thromb Hemost. 2006;32(SUPPL. 1):32–8. 4. Hoffman M, Monroe DM. Rethinking the coagulation cascade. Curr Hematol Rep. 2005;4(5):391–6. 5. MacFarlane R. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature. 1964;202:498–9. 6. Tripodi A, Mannucci PM. Abnormalities of hemostasis in chronic liver disease: Reappraisal of their clinical significance and need for clinical and laboratory research. J Hepatol. 2007;46(4):727–33. 7. Lisman T, Leebeek FWG, Mosnier LO, Bouma BN, Meijers JCM, Janssen HLA, et al. Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology. 2001;121(1):131–9. 8. Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol. 2016;51(7):629–50. 9. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365(2):147–56. 10. Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease : evidence and clinical consequences. Blood. 2010;116(6):878–85. 11. Lisman T, Bongers TN, Adelmeijer J, Janssen HLA, De Maat MPM, De Groot PG, et al. Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology. 2006;44(1):53–61. 12. Lisman T, Adelmeijer J, de Groot PG, Janssen HLA, Leebeek FWG. No evidence for an intrinsic platelet defect in patients with liver cirrhosis – studies under flow conditions. J Thromb Haemost. 2006;(4):2070–2. 13. Hollestelle MJ, Geertzen HGM, Straatsburg IH, Gulik TM Van, Mourik JA Van. Factor VIII expression in liver disease. Thromb Haemost. 2004;91(2):267–75. 14. Gatt A, Riddell A, Calvaruso V, Tuddenham EG, Makris M, Burroughs AK. Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost. 2010;8(9):1994–2000. 15. Lisman T, Bakhtiari K, Pereboom ITA, Hendriks HGD, Meijers JCM, Porte RJ. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. Journal of Hepatology. 2010. p. 355–61. 16. Bos S, Blokzijl H, van den Boom B, Lisman T, Adelmeijer J, Kamphuisen P, et al. Haemostatic Profiles are Similar across All Aetiologies of Cirrhosis. Thromb Haemost. 2019;119(02):246–53. 17. Colucci M, Binetti BM, Branca MG, Clerici C, Morelli A, Semeraro N, et al. Deficiency of Thrombin Activatable Fibrinolysis Inhibitor in Cirrhosis Is Associated With Increased Plasma Fibrinolysis. Hepatology. 2003;38(1):230–7.